Patents Assigned to Envisagenics, Inc.
  • Publication number: 20230263872
    Abstract: Provided herein are systems and methods for identifying alternative splicing derived cell surface antigens. Also provided are methods and compositions for using the identified cell surface antigens. Further provided are methods, compositions, and systems for diagnosing diseases in a subject using the identified cell surface antigens or treating diseases using the same.
    Type: Application
    Filed: August 27, 2021
    Publication date: August 24, 2023
    Applicants: Envisagenics, Inc., Envisagenics, Inc.
    Inventors: Maria Luisa Pineda, Martin Akerman, Gayatri Arun, Naomi Yudanin, Priyanka Dhingra